Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 15/100

Failure Rate

0.0%

0 terminated/withdrawn out of 9 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

22%

2 trials in Phase 3/4

Results Transparency

83%

5 of 6 completed trials have results

Key Signals

1 recruiting5 with results

Enrollment Performance

Analytics

N/A

4(50.0%)

Phase 4

2(25.0%)

Early Phase 1

1(12.5%)

Phase 1

1(12.5%)

8Total

N/A(4)

Phase 4(2)

Early Phase 1(1)

Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (9)

Showing 9 of 9 trials

NCT07101640Phase 1Recruiting

PK, Safety and Preliminary Efficacy Study of Montelukast in Critically Ill Infants With Developing Bronchopulmonary Dysplasia

Role: collaborator

NCT03185130Phase 4Completed

Intravenous Fluids in Benign Headaches Trial

Role: lead

NCT04343898Completed

Study of the Treatment and Outcomes in Critically Ill Patients With COVID-19

Role: collaborator

NCT02950753Early Phase 1Completed

Does Intravenous Lactated Ringer Solution Raise Measured Serum Lactate?

Role: lead

NCT03231345Not ApplicableCompleted

Ultrasound-guided Peripheral IJ Study

Role: lead

NCT02657031Phase 4Completed

The CHECK Trial: A Comparison of Headache Treatment in the ED: Compazine Versus Ketamine

Role: lead

NCT03360617Not ApplicableUnknown

Does a Safety Difference Exist Between IV Push and IV Piggyback Antibiotics?

Role: lead

NCT02073747Not ApplicableCompleted

The Various Effects of Gaseous Albuterol on Serum Lactate

Role: lead

NCT03042598Not ApplicableUnknown

Biphasic Ventilation Airway Management Clinical Trial

Role: lead

All 9 trials loaded